189 related articles for article (PubMed ID: 20844932)
1. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.
McNally LR; Welch DR; Beck BH; Stafford LJ; Long JW; Sellers JC; Huang ZQ; Grizzle WE; Stockard CR; Nash KT; Buchsbaum DJ
Clin Exp Metastasis; 2010 Dec; 27(8):591-600. PubMed ID: 20844932
[TBL] [Abstract][Full Text] [Related]
2. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.
Nash KT; Phadke PA; Navenot JM; Hurst DR; Accavitti-Loper MA; Sztul E; Vaidya KS; Frost AR; Kappes JC; Peiper SC; Welch DR
J Natl Cancer Inst; 2007 Feb; 99(4):309-21. PubMed ID: 17312308
[TBL] [Abstract][Full Text] [Related]
3. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling of cell lines derived from an orthotopic pancreatic tumor model reveals metastasis-associated genes.
Tarbé N; Evtimova V; Burtscher H; Jarsch M; Alves F; Weidle UH
Anticancer Res; 2001; 21(5):3221-8. PubMed ID: 11848476
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
7. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
8. The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells.
Beck BH; Welch DR
Eur J Cancer; 2010 May; 46(7):1283-9. PubMed ID: 20303258
[TBL] [Abstract][Full Text] [Related]
9. Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer.
Guan-Zhen Y; Ying C; Can-Rong N; Guo-Dong W; Jian-Xin Q; Jie-Jun W
Int J Exp Pathol; 2007 Jun; 88(3):175-83. PubMed ID: 17504447
[TBL] [Abstract][Full Text] [Related]
10. KISS1 and KISS1R expression in primary and metastatic colorectal cancer.
Matthaiou S; Kostakis ID; Kykalos S; Machairas N; Spartalis E; Ntikoudi E; Lambropoulou M; Karayiannakis A; Machairas N
J BUON; 2018; 23(3):598-603. PubMed ID: 30003725
[TBL] [Abstract][Full Text] [Related]
11. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model.
Niedergethmann M; Alves F; Neff JK; Heidrich B; Aramin N; Li L; Pilarsky C; Grützmann R; Allgayer H; Post S; Gretz N
Br J Cancer; 2007 Nov; 97(10):1432-40. PubMed ID: 17940512
[TBL] [Abstract][Full Text] [Related]
13. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of reduced VEGF activity in liver metastases of experimental pancreatic cancer.
Fukuhara M; Uchida E; Tajiri T; Aimoto T; Naito Z; Ishiwata T
J Nippon Med Sch; 2005 Jun; 72(3):155-64. PubMed ID: 16046832
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.
Zhong Y; Macgregor-Das A; Saunders T; Whittle MC; Makohon-Moore A; Kohutek ZA; Poling J; Herbst BT; Javier BM; Cope L; Leach SD; Hingorani SR; Iacobuzio-Donahue CA
Clin Cancer Res; 2017 Mar; 23(6):1607-1620. PubMed ID: 27637888
[No Abstract] [Full Text] [Related]
18. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice.
Armacki M; Polaschek S; Waldenmaier M; Morawe M; Ruhland C; Schmid R; Lechel A; Tharehalli U; Steup C; Bektas Y; Li H; Kraus JM; Kestler HA; Kruger S; Ormanns S; Walther P; Eiseler T; Seufferlein T
Gastroenterology; 2020 Sep; 159(3):1019-1035.e22. PubMed ID: 32446697
[TBL] [Abstract][Full Text] [Related]
19. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
Wang CH; Qiao C; Wang RC; Zhou WP
Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
[TBL] [Abstract][Full Text] [Related]
20. GPR54 is a target for suppression of metastasis in endometrial cancer.
Kang HS; Baba T; Mandai M; Matsumura N; Hamanishi J; Kharma B; Kondoh E; Yoshioka Y; Oishi S; Fujii N; Murphy SK; Konishi I
Mol Cancer Ther; 2011 Apr; 10(4):580-90. PubMed ID: 21282360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
